Epidemiological and clinical evaluation of hepatitis B, hepatitis C, and delta hepatitis viruses in Tajikistan.

Epidemiological and clinical evaluation of hepatitis B, hepatitis C, and delta hepatitis viruses in Tajikistan. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Epidemiological and clinical evaluation of hepatitis B, hepatitis C, and delta hepatitis viruses in Tajikistan. Abstract Text:

Anis Khan,Fuat Kurbanov,Yasuhito Tanaka,Abeer Elkady,Masaya Sugiyama,Abdusamad Dustov,Masashi Mizokami,Anis Khan,Fuat Kurbanov,Yasuhito Tanaka,Abeer Elkady,Masaya Sugiyama,Abdusamad Dustov,Masashi Mizokami,Anis Khan,Fuat Kurbanov,Yasuhito Tanaka,Abeer Elkady,Masaya Sugiyama,Abdusamad Dustov,Masashi Mizokami,

Epidemiological and clinical evaluation of hepatitis B, hepatitis C, and delta hepatitis viruses in Tajikistan. Publishing Authors By Initials

A Khan,F Kurbanov,Y Tanaka,A Elkady,M Sugiyama,A Dustov,M Mizokami,A Khan,F Kurbanov,Y Tanaka,A Elkady,M Sugiyama,A Dustov,M Mizokami,A Khan,F Kurbanov,Y Tanaka,A Elkady,M Sugiyama,A Dustov,M Mizokami,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Epidemiological and clinical evaluation of hepatitis B, hepatitis C, and delta hepatitis viruses in Tajikistan. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Journal of medical virology

VOLUME: 80

Page Numbers: 268-76

Journal Abbreviation:

ISSN: 0146-6615

DAY: 26

MONTH: Feb

YEAR: 2008

Epidemiological and clinical evaluation of hepatitis B, hepatitis C, and delta hepatitis viruses in Tajikistan. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 7705876

Epidemiological and clinical evaluation of hepatitis B, hepatitis C, and delta hepatitis viruses in Tajikistan. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Epidemiological and clinical evaluation of hepatitis B, hepatitis C, and delta hepatitis viruses in Tajikistan. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Epidemiological and clinical evaluation of hepatitis B, hepatitis C, and delta hepatitis viruses in Tajikistan.

AFFILIATION:

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: J Med Virol

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Epidemiological and clinical evaluation of hepatitis B, hepatitis C, and delta hepatitis viruses in Tajikistan Related Publications

• A case-control study of response to lamivudine therapy for 2 years in Japanese and Chinese patients chronically infected with hepatitis B virus of genotypes Bj, Ba and C.
• Accidental exposure to HCV antibody-positive blood in hospital and pre-emptive one-shot interferon alpha-2b treatment.
• Characteristics of hepatitis B virus genotype G coinfected with genotype H in chimeric mice carrying human hepatocytes.
• Classification of hepatitis B virus genotype B into 2 major types based on characterization of a novel subgenotype in arctic indigenous populations.
• Comparison of complete sequences of hepatitis B virus genotype C between inactive carriers and hepatocellular carcinoma patients before and after seroconversion.
• Development and public release of a comprehensive hepatitis virus database.
• Differences of HBV genotypes and hepatocellular carcinoma in Asian countries.
• Epidemiological and clinical evaluation of hepatitis B, hepatitis C, and delta hepatitis viruses in Tajikistan.
• Field spread of a diffracted Gaussian beam through a circular aperture.
• Hepatitis B caused by a hepatitis B surface antigen escape mutant.
• Hepatitis B virus transmission pattern and vaccination efficiency in Uzbekistan.
• Impact of daily high-dose IFNalpha-2b plus ribavirin combination therapy on reduction of ALT levels in patients with chronic hepatitis C with genotype 1 and high HCV RNA levels.
• Influence of hepatitis B virus X and core promoter mutations on hepatocellular carcinoma among patients infected with subgenotype C2.
• Long-term efficacy of preoperative radiotherapy for locally advanced low rectal cancer.
• Pelvic drainage for anterior resection revisited: use of drains in anastomotic leaks.
• Purification and cDNA cloning of a novel protease inhibitor secreted into culture supernatant by MDCK cells.
• Retroposition of the mandible in complete denture wearers.
• Suppressive effect of oral administration of branched-chain amino acid granules on oxidative stress and inflammation in HCV-positive patients with liver cirrhosis.
• Tracing hepatitis C and Delta viruses to estimate their contribution in HCC rates in Mongolia.
• Transmission of hepatitis B virus (HBV) genotypes among Japanese immigrants and natives in Bolivia.
• Two subtypes (subgenotypes) of hepatitis B virus genotype C: A novel subtyping assay based on restriction fragment length polymorphism.
• Tympanic membrane temperature in a patient with vertigo.
• Virological and clinical implication of core promoter C1752/V1753 and T1764/G1766 mutations in hepatitis B virus genotype D infection in Mongolia.
• When should "i" consider a new hepatitis B virus genotype?
• [Predicting sustained virological response in chronic hepatitis C patients treated with pegylated interferon and ribavirin using a novel highly sensitive Real-time detection PCR assay]
• [Relationship between Shenzhen HBV genotype and precore/core promoter mutation and antiviral effects]